ERBB2 and breast cancer: Here, we present the case of a patient with breast cancer in whom <sup>68</sup>Ga-diethylenetriamine pentaacetic acid anti-human epidermal growth factor receptor 2 positron emission tomography-CT was successfully employed to characterize the expression of human epidermal growth factor receptor 2 in metastatic sites.